Fiche publication
Date publication
décembre 2025
Journal
Hypertension (Dallas, Tex. : 1979)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
,
Dr WEBER Mickaël
Tous les auteurs :
Rossignol P, Clozel M, Dreier RF, Flack JM, Flamion B, Mann J, Narkiewicz K, Sassi-Sayadi M, Wang JG, Weber M, Schlaich M
Lien Pubmed
Résumé
Hypertension is a cause and consequence of chronic kidney disease (CKD). Resistant hypertension is common and often difficult to control in patients with CKD. This post hoc analysis evaluated the efficacy and safety of aprocitentan (with standardized background antihypertensive therapy) in patients with CKD and resistant hypertension, a group with high morbidity and mortality risk and limited treatment options.
Mots clés
antihypertensive agents, blood pressure, calcium channel blockers, cardiovascular diseases, renal insufficiency, chronic
Référence
Hypertension. 2025 12 9;:
